Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Better hair loss models needed for research.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

The document concludes that early diagnosis is key for treating common baldness in women, but reassurance is often the best approach as hair thinning can be a normal part of aging.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Hair loss can cause stress and mental health issues, so treatments should address both the physical and psychological aspects, involving a team of dermatologists, psychologists, and hair specialists.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

Hair follicles could be used to noninvasively monitor our body's internal clock and help identify risks for related diseases.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

People with alopecia have a higher risk of thyroid cancer.

Skin changes throughout life, from development before birth to aging effects like wrinkles, influenced by both genetics and environment.

Netherton Syndrome can cause severe skin lesions in rare cases.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

K_ATP channel gene mutations are linked to heart diseases, but more research is needed to understand the connection and treatment potential.

The document is a detailed medical reference on skin and genetic disorders.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Ashwagandha may improve hormone levels and reduce hair loss in non-classical adrenal hyperplasia.

Monilethrix causes fragile, patchy hair loss.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

New gene variants linked to a rare inherited hair loss disorder were found in three Chinese families.

Light/laser therapy can effectively increase hair density in some types of alopecia, especially androgenic alopecia and alopecia areata.

Accurate diagnosis of APL is crucial to avoid unnecessary treatments.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.